Kindred Healthcare (NYSE:KND) shares saw an uptick in trading volume on Monday . 1,535,241 shares traded hands during mid-day trading, an increase of 4% from the previous session’s volume of 1,478,157 shares.The stock last traded at $9.00 and had previously closed at $8.95.
A number of research firms have recently weighed in on KND. TheStreet downgraded shares of Kindred Healthcare from a “c-” rating to a “d+” rating in a research note on Tuesday, May 15th. Zacks Investment Research downgraded shares of Kindred Healthcare from a “buy” rating to a “hold” rating in a research note on Tuesday, April 24th. Finally, ValuEngine downgraded shares of Kindred Healthcare from a “sell” rating to a “strong sell” rating in a research note on Friday, May 4th. Three equities research analysts have rated the stock with a sell rating and five have issued a hold rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $8.33.
The company has a current ratio of 1.73, a quick ratio of 1.70 and a debt-to-equity ratio of 10.04. The company has a market cap of $816.78 million, a price-to-earnings ratio of 26.47 and a beta of 1.13.
Kindred Healthcare (NYSE:KND) last posted its earnings results on Wednesday, February 28th. The health services provider reported $0.20 EPS for the quarter, topping the consensus estimate of $0.18 by $0.02. Kindred Healthcare had a negative net margin of 11.56% and a positive return on equity of 11.38%. The business had revenue of $1.48 billion for the quarter, compared to the consensus estimate of $1.48 billion. During the same period last year, the company earned $0.05 EPS. The firm’s revenue was down 2.2% compared to the same quarter last year. equities research analysts forecast that Kindred Healthcare will post 0.64 EPS for the current year.
A number of large investors have recently bought and sold shares of the stock. Ancora Advisors LLC acquired a new stake in Kindred Healthcare during the 1st quarter worth approximately $137,000. Susquehanna Fundamental Investments LLC acquired a new stake in Kindred Healthcare during the 1st quarter worth approximately $313,000. UBS Group AG boosted its position in Kindred Healthcare by 46,724.7% during the 1st quarter. UBS Group AG now owns 2,564,122 shares of the health services provider’s stock worth $23,461,000 after buying an additional 2,558,646 shares during the period. Prosight Management LP acquired a new stake in Kindred Healthcare during the 1st quarter worth approximately $1,485,000. Finally, Water Island Capital LLC acquired a new stake in Kindred Healthcare during the 1st quarter worth approximately $28,103,000. Institutional investors and hedge funds own 88.47% of the company’s stock.
Kindred Healthcare Company Profile
Kindred Healthcare, Inc provides healthcare services in the United States. It operates through five segments: Home Health Services, Hospice Services, Hospitals, Kindred Hospital Rehabilitation Services, and RehabCare. The company provides long-term acute care (LTAC) services to post-intensive care and medically complex patients, including the critically ill and suffering from multiple organ system failures most commonly of the cardiovascular, pulmonary, kidney, gastro-intestinal, and cutaneous systems.
Receive News & Ratings for Kindred Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.